Metastatic bone damage in prostate cancer as a cause of chronic musculoskeletal pain-Reference-Cited by-同舟云学术

Metastatic bone damage in prostate cancer as a cause of chronic musculoskeletal pain

Published:2023-02-01 Issue:4 Volume:8 Page:20-24
ISSN:2409-3750
Container-title:Clinical Medicine and Pharmacology
language:en
Short-container-title:

Author:

Blashkevich O.¹

Affiliation:

1. Tula State University

Abstract

A clinical case of detection of prostate cancer with multiple bone metastases is presented. It has been clearly demonstrated that oncopathology in the early stages may go unnoticed due to the absence of specific symptoms, as well as the ability to mimic other nosologies in clinical manifestations during its progression. The importance of oncological alertness on the part of the doctor is shown, the need for medical examination is once again emphasized.

Publisher

Infra-M Academic Publishing House

Subject

General Medicine

Reference21 articles.

1. Воробьев А.В. Общие вопросы скрининга. Практическая онкология. 2010;11(2):53-59., Vorob'ev A.V. Obschie voprosy skrininga. Prakticheskaya onkologiya. 2010;11(2):53-59.

2. Yang HL, Liu T, Wang XM, Xu Y, Deng SM. Diagnosis of bone metastases: a metaanalysis comparing 18FDG PET, CT, MRI and bone scintigraphy. European Radiology 2011; 21(12): 2604-2617. DOI: 10.1007/s00330-011-2221-4, Yang HL, Liu T, Wang XM, Xu Y, Deng SM. Diagnosis of bone metastases: a metaanalysis comparing 18FDG PET, CT, MRI and bone scintigraphy. European Radiology 2011; 21(12): 2604-2617. DOI: 10.1007/s00330-011-2221-4

3. Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2014 году. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИРЦ» Минздрава России, 2015. C. 25–27, 31, 130–133., Kaprin A.D., Starinskiy V.V., Petrova G.V. Zlokachestvennye novoobrazovaniya v Rossii v 2014 godu. M.: MNIOI im. P.A. Gercena – filial FGBU «NMIRC» Minzdrava Rossii, 2015. C. 25–27, 31, 130–133.

4. von Moos R. Costa L.Gonzalez-Suarez E.et al. Management of bone health in solid tumours: from bisphosphonates to a monoclonal antibody.Cancer Treat Rev. 2019; 76: 57-67, von Moos R. Costa L.Gonzalez-Suarez E.et al. Management of bone health in solid tumours: from bisphosphonates to a monoclonal antibody.Cancer Treat Rev. 2019; 76: 57-67

5. Ревматология. Национальные рекомендации / Под ред. Е.Л. Насонова, В.А. Насоновой. М.; 2008: 562—5., Revmatologiya. Nacional'nye rekomendacii / Pod red. E.L. Nasonova, V.A. Nasonovoy. M.; 2008: 562—5.